Amarin (AMRN) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

AMRN is expected to report earnings to fall 725.00% to -6 cents per share on November 06

Q3'24

Est.

$-0.06

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.02

Q4'23

Beat

by $0.02

Q3'23

Est.

$-0.05

The last earnings report on July 31 showed earnings per share of 0 cents, beating the estimate of -3 cents. With 710.76K shares outstanding, the current market capitalization sits at 357.53M.

View a ticker or compare two or three

Compare

AMRN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For AMRN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on commercialization and development of therapeutics to improve cardiovascular health

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

112-114 St Stephens Green

Phone

+353 16699020

Employees

275

Web

https://www.amarincorp.com